Inadvertent staining of the posterior lens capsule with trypan blue dye during phacoemulsification.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
OBJECTIVE: To evaluate the effectiveness and biocompatibility of brilliant blue G (BBG) for capsular visualization for continuous curvilinear capsulorrhexis. METHODS: The capsular staining ability of BBG was evaluated at graded concentrations of 10.0, 1.0, 0.5, 0.25, 0.1, and 0.01 mg/mL in enucleated pig's eyes. The biocompatibility of BBG was assessed in rat's eyes for 2 months. The eyes were analyzed using light, fluorescence, transmission electron, and scanning electron microscopy. TUNEL (terminal deoxynucleotidyl transferase-mediated biotin-deoxyuridine triphosphate nick-end labeling) was used to detect apoptotic cells, and endothelial cell counts were analyzed using scanning electron microscopy. The results were compared using indocyanine green and trypan blue. RESULTS: The BBG improved capsular visualization, and a complete capsulorrhexis could be performed. In the rat model, no apparent toxic effect was observed using biomicroscopy during 2 months. Histologically, BBG showed satisfactory biocompatibility. Apoptotic cell death of the endothelial cells was detected in only the trypan blue group. In contrast to BBG, indocyanine green and trypan blue showed degeneration of corneal endothelial cells using transmission and scanning electron microscopy. CONCLUSION: The BBG contributed to better capsular visualization and caused no apparent complications to the corneal endothelium.Clinical Relevance The BBG is effective and safe capsular staining for continuous curvilinear capsulorrhexis.
BACKGROUND: For optimal patient satisfaction and greatest independence from spectacles after implantation of a diffractive designed multifocal intraocular lens (IOL), emmetropia with a low postoperative astigmatism must be achieved. The aim of this study was to prospectively determine patient satisfaction after implantation of diffractive designed multifocal IOLs in relation to objective parameters. PATIENTS AND METHODS: A total of 69 eyes of 50 patients without additional ocular pathology (mean age 64.8 years) received a diffractive designed multifocal IOL and were examined 12 months postoperatively. Overall patient satisfaction, visual phenomena (halos, glare), and frequency of use of reading spectacles and distance correction were assessed as subjective parameters. As objective parameters, uncorrected and best-corrected distance visual acuity (UCVA, BCVA, respectively), uncorrected, distance corrected and best-corrected near visual acuity, contrast sensitivity (Pelli-Robson charts), pre- and postoperative astigmatism, postoperative spherical equivalent and depth of focus (defocusing curve from +5.0 to -5.0 D) were measured. RESULTS: The mean overall satisfaction on a scale from 5 (excellent) to 1 (poor) was 4.49. Mean postoperative UCVA was 0.85 and BCVA was 1.03. Mean uncorrected near visual acuity was J1.04, distance corrected near visual acuity J1.0 and best corrected near visual acuity J1.0. Postoperative mean spherical equivalent was -0.17 +/- 0.43 D and absolute mean astigmatism was 0.64 D. The use of spectacles was highly correlated with postoperative spherical equivalent and absolute postoperative astigmatism. On a subjective scale from 0 (none) to 4 (very disturbing), a mean halo score of 0.45 and a mean glare score of 0.44 was recorded. Overall satisfaction was significantly correlated with UCVA, age, use of spectacles for distance purposes, contrast sensitivity, postoperative astigmatism, and postoperative spherical equivalent (P<0.05). Linear stepwise regression analysis identified UCVA as the most influential factor for overall patient satisfaction. CONCLUSIONS: For diffractive designed multifocal IOLs, emmetropia and a low astigmatism postoperatively are the most important factors for high patient satisfaction.
PURPOSE: To evaluate the rate of axial growth after congenital cataract surgery. DESIGN: Prospective observational case series. METHODS: Rate of axial growth of 158 eyes (79 children < 10 years) undergoing surgery was correlated with age at surgery, laterality, and visual axis obscuration. After measuring axial length (AL) at each follow-up, the mean AL was calculated, adding the AL of all eyes divided by their total number. Rate of axial growth is the percentage difference between preoperative mean AL and mean AL at last follow up. The temporal profile of RAG is the difference between two consecutive mean ALs with respect to the previous reading. The follow-up period was 58.96 +/- 2.02 months. The student' paired t test and independent sample t test were applied. The main outcome measure was RAG. RESULTS: Rate of axial growth in children operated at < or = 1 year (23.5%) was significantly higher than in those at < or = 3 years (4.8%; P = .0001, confidence interval [CI] 1.05-3.2) and at < or = 10 years (4.3%; P = .0001, CI 1.3-3.1). In children operated at <or = 1 year, temporal profile of RAG was higher in the first 2 years after surgery. Rate of axial growth was higher in patients with unilateral pseudophakia at < or = 1 year (25.53%) than in age-matched patients with bilateral pseudophakia (18.50%; P = .001, CI -13 to -0.2). Rate of axial growth was negligible in children with visual axis obscuration in any group. CONCLUSION: Rate of axial growth is higher in children < or = 1 year and increases until the second year after surgery. Unilateral pseudophakia revealed accelerated growth compared with bilateral pseudophakia. Visual axis obscuration does not influence rate of axial growth.
Explore the source record for details and available documents.
PURPOSE: To compare the intensity of capsule opacification with the sharp and the round optic edge variant of an open-loop hydrophobic silicone intraocular lens (IOL). DESIGN: Randomized, controlled, double-blind clinical trial with intraindividual comparison. METHODS: Fifty-one patients with bilateral age-related cataract were included (102 eyes). Each patient had had cataract surgery in both eyes and received a Microsil IOL with a sharp optic edge design (model S) in one eye and a Microsil IOL with a round optic edge design (model R) in the fellow eye. Both IOLs had an identical haptic design (nonangulated polymethylmethacrylate) and silicone optic material. The patients were examined at the slit lamp, best-corrected visual acuity was assessed, and standardized high-resolution digital retroillumination images of the posterior capsule were taken 5 years after surgery. The intensity of regeneratory posterior capsule opacification (rPCO), fibrotic PCO (fPCO), and anterior capsule opacification (ACO) was assessed subjectively at the slit lamp, and of rPCO, objectively using automated image analysis software (AQUA). The need for an Nd:YAG laser capsulotomy (Nd:YAG-LCT) was noted. RESULTS: The mean AQUA PCO score was 1.2 for the model S and 2.4 for the model R lens (P = .001). The model S lens also led to less peripheral fPCO (P = .003). Concerning ACO, there was no significant difference between both IOL groups (P = .72). Whereas no capsulotomy was required with the model S, four cases (16%) had been performed in the model R group. CONCLUSION: Five years postoperatively, the sharp-edged silicone IOL showed less rPCO and fPCO than the round-edged IOL. However, regarding ACO, there was no significant difference between both IOL styles.
PURPOSE: To examine the influence of optic material (silicone and hydrophobic acrylic) and haptic design (one-piece and three-piece open loop) of sharp optic edge intraocular lenses (IOL) on anterior capsule opacification (ACO) and capsulorrhexis contraction. DESIGN: Randomized, controlled, double-blind clinical trial with intraindividual comparison. METHODS: This study was performed at the Department of Ophthalmology, Medical University of Vienna, Austria, and comprised 210 eyes of 105 patients with bilateral age-related cataract. In group 1 (n = 53 patients), a three-piece acrylic IOL was compared with a three-piece silicone IOL. In group 2 (n = 52 patients), the three-piece acrylic IOL was compared with the one-piece acrylic IOL. One year after the operation, standardized digital slit-lamp images of ACO were taken; 1 week and 1 year after the operation, digital retroillumination images were taken to assess capsulorrhexis size. The intensity of ACO was graded objectively (score, 0% to 100%), and the capsulorrhexis area (square millimeters) was determined objectively. RESULTS: One year after surgery, the mean ACO score was 21% for the acrylic and 20% for the silicone IOL (P = .4) in group 1 and 18% for both the three-piece and one-piece acrylic IOLs (P = .87) in group 2. Concerning the amount of capsulorrhexis contraction, there was no significant difference between the IOL types that were evaluated in this study (after Bonferroni-Holm correction, P > .05). CONCLUSION: In the hydrophobic sharp optic edge IOLs that were examined, neither the optic material nor the haptic design had an influence on the amount of ACO or capsulorrhexis contraction.
PURPOSE: To compare intraoperative and postoperative effects of Nagahara phaco-chop and stop-and-chop phacoemulsification nucleotomy techniques. SETTING: Department of Ophthalmology, SBMU First Aid and Traumatology Hospital, Ankara, Turkey. METHODS: Seventy patients were evaluated prospectively in 2 groups. The Nagahara phaco-chop nucleotomy technique was performed in Group 1 (35 eyes) and the stop-and-chop technique in Group 2 (35 eyes). There were no significant between-group differences. The mean phaco time, phaco power, effective phaco time, time to achieve maximum vision, corneal thickness increase relative to the preoperative values, and time to return to the preoperative values were determined. All parameters in both groups were statistically compared using the chi-square test and the independent-samples t test. RESULTS: The mean phaco time was 1.3 minutes +/- 0.7 (SD), phaco power was 16.7% +/- 5.0%, and effective phaco time was 14.9 +/- 11.8 seconds in Group 1 and 1.8 +/- 0.9 minutes, 20.0% +/- 6.2%, and 22.3 +/- 14.2 seconds, respectively, in Group 2. The mean time to achieve maximum vision postoperatively was 6.9 +/- 3.7 days in Group 1 and 11.7 +/- 7.7 days in Group 2. The mean postoperative corneal thickness increase in Group 1 and Group 2 was 52.3 +/- 84.5 microm and 111.6 +/- 151.2 microm, respectively, and the mean time to return to preoperative pachymetry values, 9.8 +/- 5.7 days and 13.7 +/- 10.0 days, respectively. There were significant between-group differences in these parameters. CONCLUSIONS: The Nagahara phaco-chop technique had fewer negative effects on the corneal endothelium as less ultrasonic energy was used. This accelerated the functional healing process and the return to preoperative physiologic values.
A technique of achieving precise hydrodelineation, in which fluid is injected from the inside of the nucleus to the outside, is described. The desired thickness of the nucleus-epinucleus bowl can be accomplished because the right-angled cannula can direct the fluid in the desired plane. This technique is useful in eyes with posterior polar cataracts and in eyes with dense cataracts in which aggressive phacoparameters are necessary for their removal.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
PURPOSE: To assess the efficacy of lidocaine gel, bupivacaine drops, and benoxinate drops as topical anesthetic agents in cataract surgery. SETTING: Kasr El-Aini Hospital, Cairo University, Cairo, Egypt. METHODS: This prospective randomized study comprised 90 patients scheduled for routine cataract extraction. Patients were randomized into 3 groups of 30 each based on which anesthetic agent they received: lidocaine 2% gel, bupivacaine 0.5% drops, or benoxinate 0.4% drops. Subjective pain at application of the agent and intraoperatively was quantified by the patients using a verbal pain score (VPS) scale from 0 to 10. The duration of discomfort at application, duration of surgery, rate of supplemental sub-Tenon's anesthesia, and complications were recorded. RESULTS: The mean VPS at application was 2.97, 1.53, and 1.03 in the lidocaine, bupivacaine, and benoxinate groups, respectively; the VPS in the lidocaine group was statistically significantly higher than in the other 2 groups (P<.001). The mean duration of pain at application was 25 seconds, 14 seconds, and 6 seconds in the lidocaine, bupivacaine, and benoxinate groups, respectively, and was statistically significantly higher in the lidocaine group (P<.001). The mean VPS during surgery was 1.6, 4.1, and 7.1 in the lidocaine, bupivacaine, and benoxinate groups; the lidocaine group had a statistically significantly lower mean VPS than the other 2 groups (P<.001). The incidence of supplemental sub-Tenon's injection was 3.3%, 10.0%, and 73.3%, respectively, and was statistically significantly lower in the lidocaine and bupivacaine groups than in the benoxinate group (P<.001). The patients' overall satisfaction was statistically significantly higher in the lidocaine and bupivacaine groups than in the benoxinate group (93.3%, 83.3%, and 33.3%, respectively) (P<.001). Three patients in the lidocaine group had corneal haze at the time of surgery, which was not statistically significant (P>.1). CONCLUSIONS: Lidocaine gel was a better topical anesthetic agent than bupivacaine and benoxinate drops. Bupivacaine drops were effective in providing deep topical anesthesia.
PURPOSE: To compare the inhibiting effect on posterior capsule opacification (PCO) of a silicone intraocular lens (IOL) with a sharp posterior optic edge (ClariFlex OptiEdge, Advanced Medical Optics) and a silicone IOL with a round optic edge (PhacoFlex SI-40, Advanced Medical Optics). SETTING: Department of Ophthalmology, University of Vienna, Vienna, Austria. METHODS: This prospective randomized patient- and examiner-masked study comprised 104 eyes of 52 patients with bilateral age-related cataract. All patients had cataract surgery in both eyes and received a sharp-edged IOL in 1 eye and a round-edged IOL in the other eye. Postoperative examinations were at 1 week, 1 and 6 months, and 1 year. Digital slitlamp and retroillumination images were taken of each eye. The amount of PCO was assessed subjectively at the slitlamp and objectively using Automated Quantification of After-Cataract (AQUA) automated-image analysis software. RESULTS: The sharp-edged IOL group had significantly less regeneratory and fibrotic PCO 1 month, 6 months, and 1 year after surgery. The mean AQUA PCO score (scale 0 to 10) was 0.71 in the sharp-edged IOL group and 1.40 in the round-edged IOL group (P<.001). The sharp-edged IOL group had less peripheral fibrotic PCO. There was no significant difference between the 2 IOL groups in patient reports of edge glare. CONCLUSION: The sharp-edged design of the ClariFlex OptiEdge silicone IOL led to significantly less PCO than the round-edged PhacoFlex SI-40 IOL 1 year postoperatively.
PURPOSE: To evaluate the long-term effect of anterior capsule polishing on anterior capsule opacification (ACO) and peripheral fibrotic posterior capsule opacification (PCO). SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: This randomized double-blind study comprised 104 eyes of 52 patients with bilateral age-related cataract. All patients received round-edged intraocular lenses (IOLs); 26 received an SI-40 IOL (Advanced Medical Optics Inc.) in both eyes, and 26 received a Silens6 IOL (Domilens) in both eyes. Both IOLs consist of different silicone material and have different haptic angulation. The SI-40 IOL has 13.0 mm open-loop poly(methyl methacrylate) (PMMA) haptics angulated by 10 degrees. The Silens6 IOL has 12.5 mm open-loop PMMA haptics with no angulation. In 1 eye, the anterior capsule was extensively polished. The anterior capsule was left unpolished in the contralateral eye, which acted as a control. Digital slitlamp photographs of the ACO and fibrotic PCO were taken with a standardized technique for 3 years postoperatively. The intensity of ACO was measured objectively (score 0% to 100%) using Adobe Photoshop software. Fibrotic PCO was graded subjectively (score 0 to 4). RESULTS: The mean ACO was 17% in the polished eyes and 26% in the control eyes (P = .0001). The mean fibrotic PCO score was 0.5 and 1.0, respectively (P = .0007). The mean ACO was 15% in the polished SI-40 eyes and 26% in the control SI-40 eyes (P = .01). It was 19% in the polished Silens6 eyes and 26% in the control Silens6 eyes (P = .003). The mean fibrotic PCO score was 0.4 in the polished SI-40 eyes and 1.1 in the control SI-40 eyes (P = .0006). It was 0.6 in the polished Silens6 eyes and 0.9 in the control Silens6 eyes (P = .08). CONCLUSIONS: Three years after surgery, eyes in which the anterior capsule was extensively polished had less ACO and fibrotic PCO with both round-edged silicone IOLs. In eyes with Silens6 IOLs, however, the reduction in fibrotic PCO was not significant.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
PURPOSE: To compare the protective effect of Healon5 (sodium hyaluronate 2.3%) and Amvisc Plus (sodium hyaluronate 1.6%) against corneal edema and their association with postoperative intraocular pressure (IOP) spikes in patients having phacoemulsification and intraocular lens (IOL) implantation. SETTING: Ophthalmology department of a general hospital. METHODS: One hundred forty patients were randomly assigned to have surgery with Healon5 (n = 70) or Amvisc Plus (n = 70). One eye of each patient was analyzed. Data collected preoperatively included best corrected visual acuity (BCVA) and IOP. Central ultrasonic pachymetry was performed in all patients. The same ophthalmologist performed all surgeries. The IOP and central corneal thickness (CCT) were measured 1 and 4 days and 1 month after surgery. The BCVA was also assessed at 1 month. RESULTS: There were no significant preoperative differences between the Healon5 and Amvisc Plus groups in sex, age, ocular pathology, BCVA, IOP, or CCT. Intraoperative variables were similar between groups, but it took significantly longer to remove the Healon5. Postoperatively, there were no differences between groups in the evolution of CCT or of IOP. Intraocular pressure spikes over 30 mm Hg were detected at 1 day in 7 patients in the Healon5 group and 2 patients in the Amvisc Plus group (10.0% versus 2.9%; P = .165). CONCLUSIONS: Both OVDs were beneficial in a wide range of cataract patients. However, the results suggest a tendency toward a higher complication rate with Healon5.